Company intelligence / Profile preview

ReGain

Mysore, Karnataka, India

Ownership: Private
Development stage: Other

Overview

Regain Biotechnology Private Limited is an Indian biotechnology company incorporated in 2004, focused on developing natural product-based solutions for various indications including dermatitis, cancer, fungal infections, diabetes, and obesity. The company appears to be in the pre-clinical development stage, with reported zero revenue in recent financial years (2021-2023) and no recent financial updates or AGMs, suggesting it may be dormant or operating at a minimal level.

Therapeutic areas: OncologyInfectious DiseasesEndocrinologyDermatology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on ReGain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReGain.

Explore the full profile